Skip to main content

Advertisement

Log in

A Patient-Centered Approach to Wait Times in the Surgical Management of Breast Cancer in the Province of Ontario

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Wait time for breast cancer is an important contributor to cancer outcomes and patient satisfaction. This study sought to define a patient-centered wait time by measuring the time from the first abnormal imaging to definitive surgery. The authors hypothesized that multiple preoperative investigations significantly increase the patient-centered wait time.

Methods

A retrospective analysis of prospectively maintained databases at the Institute for Clinical and Evaluative Sciences in Ontario, Canada was performed. Women undergoing primary surgery for invasive breast cancer from 2003 to 2011 were evaluated. The median wait time between the first abnormal imaging and definitive surgery was calculated. Uni- and multivariable analyses were performed to identify characteristics of the patients, treating institution, and diagnostic pathway that contribute significantly to the patient-centered wait time.

Results

Our final cohort consisted of 42,179 patients: 31,837 (75 %) who had breast conserving surgery and 10,342 (25 %) who underwent mastectomy. The median wait time from the first abnormal imaging to definitive surgery was 52 days (intraquartile range 35–76 days). In adjusted analysis, older patient age, later year of surgery, additional preoperative imaging, and biopsies beyond those required for diagnosis significantly and independently extended the surgical wait time. Preoperative consultations and institutional factors such as volume of breast surgery performed and geographic location also independently had an impact on surgical wait time.

Conclusions

This study defined a novel patient-centered measure of surgical wait time that more fully embraces the wait experienced by the patient. Many common preoperative interventions had a significant impact on overall wait time experienced by the patient. Evidence-based quality initiatives to coordinate appropriate investigations are needed to reduce wait times.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. World Health Organization. GLOBOCAN 2012: estimated cancer incidence, mortality, and prevalence worldwide in 2012.Updated 2014. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 25 March 2014.

  2. Balduzzi A, Leonardi MC, Cardillo A, et al. Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy. Cancer Treat Rev. 2010;36:443–50.

    Article  PubMed  Google Scholar 

  3. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119–26.

    Article  CAS  PubMed  Google Scholar 

  4. Shin DW, Cho J, Kim SY, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013;20:2468–76.

    Article  PubMed  Google Scholar 

  5. Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013;148:516–23.

    Article  PubMed  Google Scholar 

  6. Vujovic O, Yu E, Cherian A, et al. Effect of interval to definitive breast surgery on clinical presentation and survival in early-stage invasive breast cancer. Int J Radiat Oncol Biol Phys. 2009;75:771–4.

    Article  PubMed  Google Scholar 

  7. Dickerson SS, Alqaissi N, Underhill M, Lally RM. Surviving the wait: defining support while awaiting breast cancer surgery. J Adv Nurs. 2011;67:1468–79.

    Article  PubMed  Google Scholar 

  8. Drageset S, Lindstrom TC, Giske T, Underlid K. Being in suspense: women’s experiences awaiting breast cancer surgery. J Adv Nurs. 2011;67:1941–51.

    Article  PubMed  Google Scholar 

  9. Cancer Care Ontario. Wait time targets. http://www.health.gov.on.ca/en/pro/programs/waittimes/surgery/target.aspx. Updated 2014. Accessed 10 April 2014.

  10. http://www.lhins.on.ca/.

  11. Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253:779–85.

    Article  PubMed  Google Scholar 

  12. Plotogea A, Chiarelli AM, Mirea L, et al. Factors associated with wait times across the breast cancer treatment pathway in ontario. Springerplus. 2013;2:388-1801-2-388. eCollection 2013.

  13. Angarita FA, Acuna SA, Fonseca A, Crystal P, Escallon J. Impact of preoperative breast MRIs on timing of surgery and type of intervention in newly diagnosed breast cancer patients. Ann Surg Oncol. 2010;17(Suppl 3):273–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank Mr. Refik Saskin and Mr. Jagadish Rangrej for their assistance with the statistical analysis.

Disclosure

Drs. Cordeiro, Dixon, Coburn and Holloway have no financial affiliations to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Erin Cordeiro MD, MSc, FRCSC.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cordeiro, E., Dixon, M., Coburn, N. et al. A Patient-Centered Approach to Wait Times in the Surgical Management of Breast Cancer in the Province of Ontario. Ann Surg Oncol 22, 2509–2516 (2015). https://doi.org/10.1245/s10434-014-4320-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-014-4320-3

Keywords

Navigation